Dr. Mathewos Assefa is a consultant internist and oncologist working at Addis Ababa Univerity's School of Medicine's Oncology Department. After completing high school he joined Jimma University and received his M.D. He then worked as General Medical Practitioner in Gondar Hospital. In 1997 he joined the Department of Internal Medicine, AAU and completed his specialization in 2000. After specialization he served as an assistant professor of medicine at Jimma University for one year and joined Addis Ababa University, Department of Internal Medicine in 2002. He later did his training in Radiation Oncology for four years at University of Witswatersrand in South Africa and was awarded a Fellow of Radiation Oncologist of SA. He then moved to the oncology department and worked as consultant oncologist and later head of the department from June 2012 to December 2015. Aside from clinical care and teaching, he has been involved in various research projects exploring cervical and breast cancer in Ethiopia with more than 15 collaborative publications. Dr. Assefa serves as the head of the Addis Ababa City Cancer Registry, the first population-based cancer registry in Ethiopia and Board Chairman of Ye-Ethiopia Cancer Association.
● Jimma University, 1994 (Medical Degree)
● Addis Ababa University, 2000 (Postgraduate)
● University of the Wotswatersrand, 2007 (Fellowship)
1. The prevalence of Estrogen receptor – negative breast cancer in Ethiopia. Eva JK, Assefa Mathewos, Abrha A, Tigeneh W, Ahmedin J, Martin V, Erdme K, Anne R, Solomon B, Christopher T, Andreas S, Tufa G, Pietro T, Bekuretsion Y. BMC Cancer 2014, 14:895
2. Breast cancer survival in Ethiopia: A cohort study of 1,074 women. E.J. Kantlhardt, P. Zerche, Assefa Mathewos A, Addisie A, Aynalem T. Wondemagegnehu, T. Ersumo, A Reeler, B. Yonas, M. Tinnsae, A. Jemal, C. Thompson, A. Stang S. Bogale. Int. J.Cancer 135,702-709(2014)
3. Cervical Cancer in Ethiopia: Survival of 1,059 patients who receive Oncologic Therapy. Eva JK, Ulrike M, Matthias B, Adamu A, Pietro T, Bekurtsion Y, Petros H, Andreas S, Christoph T, Dirk V, Tufa G, Yirgy GH, Tigneh W, Abrha A, Assefa Mathewos, The Oncologist 2014; 19:727–734
4. Qat use and Esophageal cancer in Ethiopia: A pilot case control study. Maria EL, Mathewos Assefa, Endale K, Abate S, Tufa G, Yared T, Nigatu E, Gilles F, Kurt S, Elizabeth W, Abrham A, Joachim S,Ahmedin J. PLOS one 10:1371 2017
5. First data from a population based cancer registry in Ethiopia. Genebo T, Asmare S, Assefa Mathewos, Adamu A, Solomon B, Tigeneh W, Abrha A, Bekele A, Hailemariam D, Wodater B, Eric S, Rafael M, Fredie B, Ahmedin J. Cancer Epidemiology 53(2018) 93-98
6. Cervical cancer patient presentation and survival in the only oncology referral Hospital, Ethiopia: a retrospective cohort study. Muluken G, Adamu A, Sofonias G, Wondemu A, Israel M, Ulrike M, Tigist Y, Mathias B, Mathewos Assefa, Ahmedin J, Eva JK. Infectious agent and cancer 12: 61(2017)
7. Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV – positive women attending public health centers in Addis Ababa City, Ethiopia. Saba S, Adamu A, Muluken G, Selamawit H, Wondemu A, Sofonias G, Eva JK, Mathewos Assefa, Ahemedin J Cancer Medicine 2018 7(3) 603-612
8. Vulvar cancer In Ethiopia: A cohort study on the characteristics and survival of 86 patients. Eric S, Assefa Mathewos, Tigeneh W, Abrha W, Tufa G, Swantje P, Genebo T, Adamu A, Andreas W, Susanne U, Christoph T, Ahmedin J, Eva JK Medicine (2018)97:9
9. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors. McCormack VA, Menya D, Munishi MO, Dzamalala C, Gamelseed N, Leon Roux M, Assefa Mathewos, Osano O, Watts M, Mwasamwaja AO, Mmbega BT, Murphy G, Abnet CC, Dawsey SM, Schuz J. Int J. Cancer 2017 140(2):259-271
10. Estimates of cancer Incidence in Ethiopiain 2015 using population based registry data. Solomon M, Mahlet K, Mathewos A, Binyam T, Getamesay A, Miheret W, Girma A, Ahmedin J, Timothy R, Stephane V. Journal of Global Oncology 160.004, 2018"